
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
In situ carcinoma
Solid papillary DCIS
Reviewer: Dina Kandil, M.D. (see Reviewers
page)
Revised: 8 November 2012, last major update January 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
General
=========================================================================
Clinical behavior:
● Indolent behavior if no invasion
● Can be associated with invasive colloid/mucinous or neuroendocrine carcinomas
(Am J Surg Pathol 1995;19:1237, Pathol Int 2007;57:421)
● With invasion, patients often die of disease
(Am J Surg Pathol 2006;30:501)
Terminology
=========================================================================
● Also called neuroendocrine DCIS
Epidemiology
=========================================================================
● Uncommon (2% of breast cancer)
● Age 60+ years
Case reports
=========================================================================
● Solid and cystic papillary carcinoma
(Ann Diagn Pathol 2004;8:126)
Micro description
=========================================================================
● Circumscribed, large cellular nodules separated by bands of dense fibrosis
● Network of fibrovascular cores, but discrete papillae are not identified
● Solid growth with cellular streaming and low grade, ovoid or spindled cells, resembling usual ductal hyperplasia
● Cells may have endocrine features with granular eosinophilic cytoplasm and fine chromatin
● May have pseudorosettes with palisading around small vascular spaces
● Often mitotic figures
● May have intracytoplasmic and extracellular mucin
Micro images
=========================================================================

Solid tumor with focal fibrovascular stroma

Solid variant with spindling

Inconspicuous fronds centrally (AFIP)
Tumor cells in cords and festoons, with well-defined fibrovascular septa and vascular cores
Virtual slides
=========================================================================
Cytology description
=========================================================================
● Malignant features include hypercellularity, highly discohesive clusters, numerous isolated cells and severe overcrowding
● Benign features include small and bland nuclei, low nuclear-cytoplasmic ratio and inconspicuous nucleoli
(Diagn Cytopathol 2007;35:417)
Positive stains
=========================================================================
● Chromogranin or synaptophysin in 50%, ER and PR
Negative stains
=========================================================================
● Usually negative for myoepithelial markers
(Histopathology 2007;51:657),
including CK5/6, but entrapped benign and myoepithelial cells may be positive
(Hum Pathol 2006;37:787)
● 34betaE12 (Virchows Arch 2007;450:539), HER2
Differential diagnosis
=========================================================================
● Usually ductal hyperplasia involving a papilloma: no atypia, mosaic staining pattern with CK5/6+
● LCIS: no fibrovascular septa, no papillary features
● Solid variant of adenoid cystic carcinoma: biphasic with small inconspicuous intercalated ducts mixed with myoepithelium and small collagenous spherules
● Metastatic carcinoid: clinical history of primary, may not be papillary, usually ER negative
End of Breast malignant, males, children > In situ carcinoma > Solid papillary DCIS
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).